On chromosome 19, the translocation occurred within a previously uncharacterized transcriptional unit for which Cleary et al. (1988) proposed the designation LYL1. An RNA of about 1.5 kb was transcribed from this gene in a wide variety of hematolymphoid cell lines. The t(7;19) resulted in truncation of the LYL1 gene and production of abnormal-sized RNAs, suggesting a role for LYL1 in the pathogenesis of this leukemia. By fluorescence in situ hybridization, Trask et al. (1993) assigned the LYL1 gene to 19p13.2-p13.1. Kuo et al. (1991) mapped the mouse Lyl-1 gene to chromosome 8, thereby defining a new region of homology of synteny with human 19p. The mapping was achieved in an interspecific backcross using a RFLP. The predicted mouse Lyl-1 protein was 78% identical to human LYL1.

Rat Protein lyl-1 (LYL1) ELISA Kit employs a two-site sandwich ELISA to quantitate LYL1 in samples. An antibody specific for LYL1 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyLYL1 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for LYL1 is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of LYL1 bound in the initial step. The color development is stopped and the intensity of the color is measured.

Rat Protein lyl-1 (LYL1) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/rat-protein-lyl-1-lyl1-elisa-kit-kte100883/

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.